SLC31A1 and non-small cell lung carcinoma: Taken together, these functional studies revealed that rs10759637 in SLC31A1 3′UTR could modulate the microRNA-3′UTR interaction and thereby decrease gene expression, thus proposing a possible underlying mechanism for the genetic association between SLC31A1 polymorphism and clinical outcomes of platinum-based chemotherapy in NSCLC patients.